.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Covington
Teva
Medtronic
Cantor Fitzgerald
Chubb
Dow
Express Scripts
Cipla

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019693

« Back to Dashboard

NDA 019693 describes DECABID, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the DECABID profile page.

The generic ingredient in DECABID is indecainide hydrochloride. Additional details are available on the indecainide hydrochloride profile page.

Summary for 019693

Tradename:1
Applicant:1
Ingredient:1
Patents:0

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 50MG BASE
Approval Date:Dec 29, 1989TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 75MG BASE
Approval Date:Dec 29, 1989TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 100MG BASE
Approval Date:Dec 29, 1989TE:RLD:No

Expired Orange Book Patents for NDA: 019693

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-003Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-001Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-003Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-003Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-002Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-002Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-002Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-001Dec 29, 1989► Subscribe► Subscribe
LillyDECABIDindecainide hydrochlorideTABLET, EXTENDED RELEASE;ORAL019693-001Dec 29, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Julphar
Queensland Health
McKesson
Chinese Patent Office
Boehringer Ingelheim
AstraZeneca
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot